Identification and Characterization of a New Potent Inhibitor Targeting CtBP₁/BARS in Melanoma Cells

Researchers identified a potent and selective inhibitor of C-terminal-binding protein 1/brefeldin A ADP-ribosylation substrate (CtBP1/BARS) active in cellular and melanoma animal models.